Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia

Background and Aim. Because genetic and geographic variations in intestinal microbiota are known to exist, the focus of this study was to establish an estimation of microbiota in colorectal cancer (CRC) patients in Saudi Arabia by means of metagenomic studies. Methods. From July 2010 to November 201...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed O. Alomair, Ibrahim Masoodi, Essam J. Alyamani, Abed A. Allehibi, Adel N. Qutub, Khalid N. Alsayari, Musaad A. Altammami, Ali S. Alshanqeeti
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/5284754
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556665777422336
author Ahmed O. Alomair
Ibrahim Masoodi
Essam J. Alyamani
Abed A. Allehibi
Adel N. Qutub
Khalid N. Alsayari
Musaad A. Altammami
Ali S. Alshanqeeti
author_facet Ahmed O. Alomair
Ibrahim Masoodi
Essam J. Alyamani
Abed A. Allehibi
Adel N. Qutub
Khalid N. Alsayari
Musaad A. Altammami
Ali S. Alshanqeeti
author_sort Ahmed O. Alomair
collection DOAJ
description Background and Aim. Because genetic and geographic variations in intestinal microbiota are known to exist, the focus of this study was to establish an estimation of microbiota in colorectal cancer (CRC) patients in Saudi Arabia by means of metagenomic studies. Methods. From July 2010 to November 2012, colorectal cancer patients attending our hospital were enrolled for the metagenomic studies. All underwent clinical, endoscopic, and histological assessment. Mucosal microbiota samples were collected from each patient by jet-flushing colonic mucosa with distilled water at unified segments of the colon, followed by aspiration, during colonoscopy. Total purified dsDNA was extracted and quantified prior to metagenomic sequencing using an Illumina platform. Satisfactory DNA samples (n=29) were subjected to metagenomics studies, followed by comprehensive comparative phylogenetic analysis. An equal number of healthy age-matched controls were also examined for colonic mucosal microbiota. Results. Metagenomics data on 29 patients (14 females) in the age range 38–77 years were analyzed. The majority 11 (37%) of our patients were overweight (BMI = 25–30). Rectal bleeding was the presenting symptom in 18/29 (62%), while symptomatic anemia was the presenting symptom in 11/29 (37%). The location of colon cancer was rectal in 14 (48%), while cecal growth was observed in 8 (27%). Hepatic flexure growth was found in 1 (3%), descending colonic growth was found in 2 (6%), and 4 (13%) patients had transverse colon growth. The metagenomics analysis was carried out, and a total of 3.58G reads were sequenced, and about 321.91G data were used in the analysis. This study identified 11 genera specific to colorectal cancer patients when compared to genera in the control group. Bacteroides fragilis and Fusobacterium were found to be significantly prevalent in the carcinoma group when compared to the control group. Conclusion. The current study has given an insight into the microbiota of colorectal cancer patients in Saudi Arabia and has identified various genera significantly present in these patients when compared to those of the control group.
format Article
id doaj-art-3d5445e3bc09496a9d9fafcc675dd6a5
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-3d5445e3bc09496a9d9fafcc675dd6a52025-02-03T05:44:44ZengWileyGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/52847545284754Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi ArabiaAhmed O. Alomair0Ibrahim Masoodi1Essam J. Alyamani2Abed A. Allehibi3Adel N. Qutub4Khalid N. Alsayari5Musaad A. Altammami6Ali S. Alshanqeeti7Gastroenterology & Hepatology Department, King Fahad Medical City, Riyadh, Saudi ArabiaGastroenterology & Hepatology Department, King Fahad Medical City, Riyadh, Saudi ArabiaNational Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi ArabiaGastroenterology & Hepatology Department, King Fahad Medical City, Riyadh, Saudi ArabiaGastroenterology & Hepatology Department, King Fahad Medical City, Riyadh, Saudi ArabiaGastroenterology & Hepatology Department, King Fahad Medical City, Riyadh, Saudi ArabiaNational Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi ArabiaNational Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi ArabiaBackground and Aim. Because genetic and geographic variations in intestinal microbiota are known to exist, the focus of this study was to establish an estimation of microbiota in colorectal cancer (CRC) patients in Saudi Arabia by means of metagenomic studies. Methods. From July 2010 to November 2012, colorectal cancer patients attending our hospital were enrolled for the metagenomic studies. All underwent clinical, endoscopic, and histological assessment. Mucosal microbiota samples were collected from each patient by jet-flushing colonic mucosa with distilled water at unified segments of the colon, followed by aspiration, during colonoscopy. Total purified dsDNA was extracted and quantified prior to metagenomic sequencing using an Illumina platform. Satisfactory DNA samples (n=29) were subjected to metagenomics studies, followed by comprehensive comparative phylogenetic analysis. An equal number of healthy age-matched controls were also examined for colonic mucosal microbiota. Results. Metagenomics data on 29 patients (14 females) in the age range 38–77 years were analyzed. The majority 11 (37%) of our patients were overweight (BMI = 25–30). Rectal bleeding was the presenting symptom in 18/29 (62%), while symptomatic anemia was the presenting symptom in 11/29 (37%). The location of colon cancer was rectal in 14 (48%), while cecal growth was observed in 8 (27%). Hepatic flexure growth was found in 1 (3%), descending colonic growth was found in 2 (6%), and 4 (13%) patients had transverse colon growth. The metagenomics analysis was carried out, and a total of 3.58G reads were sequenced, and about 321.91G data were used in the analysis. This study identified 11 genera specific to colorectal cancer patients when compared to genera in the control group. Bacteroides fragilis and Fusobacterium were found to be significantly prevalent in the carcinoma group when compared to the control group. Conclusion. The current study has given an insight into the microbiota of colorectal cancer patients in Saudi Arabia and has identified various genera significantly present in these patients when compared to those of the control group.http://dx.doi.org/10.1155/2018/5284754
spellingShingle Ahmed O. Alomair
Ibrahim Masoodi
Essam J. Alyamani
Abed A. Allehibi
Adel N. Qutub
Khalid N. Alsayari
Musaad A. Altammami
Ali S. Alshanqeeti
Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
Gastroenterology Research and Practice
title Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
title_full Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
title_fullStr Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
title_full_unstemmed Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
title_short Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia
title_sort colonic mucosal microbiota in colorectal cancer a single center metagenomic study in saudi arabia
url http://dx.doi.org/10.1155/2018/5284754
work_keys_str_mv AT ahmedoalomair colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT ibrahimmasoodi colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT essamjalyamani colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT abedaallehibi colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT adelnqutub colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT khalidnalsayari colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT musaadaaltammami colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia
AT alisalshanqeeti colonicmucosalmicrobiotaincolorectalcancerasinglecentermetagenomicstudyinsaudiarabia